Powerful Medical Receives €40 Million IPCEI Grant — read the full story

Powerful Medical
11. October 2024

Towards a New Classification of MI (This Week in Cardiology, by Dr. John Mandrola)

Smartphone showing This Week in Cardiology podcast episode from October 11, 2024, discussing a new classification of myocardial infarction from STEMI/NSTEMI to Occlusion MI

About the Podcast

This Week in Cardiology is hosted by Dr. John Mandrola, a practicing cardiologist and writer, known for sharp insights into clinical research and evolving paradigms in cardiovascular medicine. The podcast highlights evidence that challenges long-held dogma and impacts real-world care.

Summary of the Episode

In this episode, Dr. Mandrola reviews a JACC Advances state-of-the-art paper questioning the long-standing STEMI/NSTEMI classification and proposing a shift to Occlusion MI (OMI) vs non-OMI.

  • Roughly half of patients with acutely occluded coronary arteries do not show ST elevation on ECG.
  • Nearly 1 in 3 NSTEMI patients actually have an occlusion and could benefit from emergent PCI.
  • The current paradigm hides false negatives — patients with occlusion but without ST elevation are mislabeled as NSTEMI, delaying life-saving treatment.
  • Authors propose four steps:
    1. Change the language to OMI vs non-OMI.
    2. Update the medical record to reflect OMI vs non-OMI.
    3. Transition “code STEMI” to “code OMI.”
    4. Improve early diagnosis in prehospital and ED settings using AI, ECG expertise, and point-of-care ultrasound.
  • Dr. Mandrola stresses that AI tools like PMcardio Queen of Hearts™ and better ECG education can help identify subtle occlusions often missed under the old paradigm.

“This may be the most important topic I’ve covered in a long time: OMI, not STEMI or NSTEMI. It’s time for a Kuhn-like scientific revolution.”
— Dr. John Mandrola, This Week in Cardiology

🎧 Listen to the episode: Official page | Spotify | Apple Podcasts

Powerful Medical

Powerful Medical leads one of the most important shifts in modern medicine by augmenting human-made clinical decisions with artificial intelligence. Our primary focus is on cardiovascular diseases, the world’s leading cause of death.
Powerful Medical leads one of the most important shifts in modern medicine by augmenting human-made clinical decisions with artificial intelligence. Our primary focus is on cardiovascular diseases, the world’s leading cause of death.
About PMcardio:

PMcardio is a CE-certified AI that reads ECGs and offers a complex assessment of 49 cardiac conditions. Clinically validated in 15+ studies and trusted by over 100,000 clinicians, it delivers rapid, expert‑level interpretations, empowering emergency physicians, GPs, nurses, paramedics, and cardiologists to act with confidence at the point of care. Available for Individuals and Organizations.

Share this article

Don't miss these

PMcardio Exhibits at TCT Conference 2025 in San Francisco

We’re proud to share that PMcardio and the Queen of Hearts™ (STEMI AI ECG model) will be prominently featured at Transcatheter Cardiovascular Therapeutics (TCT) 2025, the largest interventional cardiology conference in the U.S., taking place October 25–27, 2025 in San Francisco, California.
Smartphone displaying RCEM Learning podcast episode “September 2025” featuring discussion of PMcardio’s Queen of Hearts™ AI outperforming doctors in ECG interpretation

Can AI Outperform Doctors in ECG Interpretation? (RCEM Learning Podcast, by Dr. Andy Neill and Dr. Dave McCreary)

In this RCEM Learning Podcast episode, Andy and Dave explore a study comparing doctors and PMcardio’s Queen of Hearts™ AI in ECG interpretation. Physicians achieved ~65% accuracy, while the AI reached ~89%, outperforming even cardiologists in spotting subtle occlusions — a shift with major implications for emergency medicine.

Join over 100,000 healthcare professionals who are already taking advantage of AI